Quince Therapeutics no salary increase for 2024; option grants to officers

Quince Therapeutics, Inc.

No salary increase for executive officers in 2024; Committee approved stock option grants.
CEO Dirk Thye: $302,500 bonus, 1,500,000 options vesting monthly over 4 years.
President Charles Ryan: $70,000 bonus, 145,000 options; COO Brendan Hannah: $178,500 bonus, 600,000 options.
Option grants effective Feb 1, 2024 under 2019 Equity Incentive Plan; vesting over 4 years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.